Lupin Limited FII & DII Activity

Today's Institutional Flow

Foreign Institutional Investors (FII) record a net cash inflow of ₹871.83 Cr in Lupin Limited today, while Domestic Institutional Investors (DII) add ₹643.35 Cr in cash; this inflow reflects renewed interest after recent earnings beat and pipeline updates. The combined cash inflow reaches ₹1,515.18 Cr, indicating strong buying pressure from both foreign and domestic camps, and underscores the stock’s liquidity resilience amid market volatility. No block or bulk trades are reported for the stock, reinforcing that the activity is driven primarily by standard market orders, which are typical for a mid‑cap pharmaceutical name.

Trend vs 5-Day Average

The day’s FII cash inflow contrasts with a five‑day average outflow of ₹‑894.74 Cr, showing a reversal in foreign sentiment. DII cash purchases also exceed their five‑day average of ₹2,592.03 Cr, albeit at a lower magnitude, suggesting a continuation of domestic buying momentum.

F&O Positioning Data

FII positions in futures and options rise by ₹643,395 Cr, reflecting aggressive speculative or hedging activity. The index futures long‑to‑short ratio stands at 1.2, indicating a modest net long bias among foreign traders.

Healthcare Sector Flow

Across the broader healthcare sector, FIIs have been net sellers over the past week while DIIs maintain a consistent net buying stance, widening the sectoral divergence.